In January 2024, Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has become the first in India to launch a biosimilar of the anti-diabetic drug liraglutide, under the brand name Lirafit
What Does the Current Research Say About Semaglutides Liver Safety Profile
Bacteriocins have shown great efficacy towards several microbe-borne diseases, including methicillin-resistant Streptococcus aureus (MRSA) 69
In therapeutic settings, the effects of global GSH depletion or supplementation are likely to depend on disease context and cellular state
AOD9604 is a modified form of the Amino Acid 176-191 of the GH polypeptide
The FDA label explicitly states this knowledge gap, requiring healthcare providers and patients to make individualized decisions weighing maternal treatment needs against theoretical infant risks